Motley Fool  May 11  Comment 
Contrary to what their price-to-earnings ratios may suggest, these three stocks could be a great deal.
GenEng News  Apr 6  Comment 
Of the two sister angiotensin II receptors, one has become a reliable drug target, while the other has remained something of a puzzle. The reliable one, known as AT1, has inspired many of the hypertension medications currently on the market. The...
Motley Fool  Feb 15  Comment 
Here's what makes the pipelines of Celgene, Ionis, and Ligand among the best of all biotechs.

You may also be interested in articles related to Ligand Pharmaceuticals (LGND):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki